45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Z. Ping Lin, PhD

Associate Research Scientist
Yale University School of Medicine
333 Cedar Street
P.O. Box 208066
New Haven, CT
USA 06510

Papers:
211 - Poster Session A MK-2206 sensitizes BRCA2 mutant ovarian adenocarcinoma to cisplatin and poly ADP (adenosine diphosphate)-ribose polymerase (PARP) inhibitor therapy